Investing Profile

Robert Garland

VCInvestor
Venture Partner at New Enterprise Associates (NEA)
nea.comSan Francisco, California
Photo of Robert Garland, Venture Partner at New Enterprise Associates (NEA)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$2.0M - $50.0M
$25.0M
10
$6.2B
CompanyStageDateRound SizeTotal Raised
Cleave Therapeutics
Series BAug 2016$37M
Series AApr 2013$10M
$47M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA))
Sagimet Biosciences
Series DDec 2014$29M
Series CJun 2013$20M
Series UnknownOct 2012$8M
Series UnknownJan 2012$20M
Series BJul 2009$30M
$190M
Co-investors: Beth Seidenberg (Kleiner Perkins), David Mott (Mott Family Capital)
Trevena
Series BJul 2010$35M
Series AMar 2008$24M
$70M
Co-investors: Terry McGuire (Polaris Partners), Farah Champsi (InterWest), Martin Alexander Gershon (Endeavor Venture Funds)
Cardioxyl Pharmaceuticals
Series ADec 2006$15M
$58M
Co-investors: James Barrett